ADMA Biologics (ADMA)
US Market

ADMA Biologics (ADMA) Financial Statements


ADMA Biologics Financial Overview

ADMA Biologics's market cap is currently ―. The company's EPS TTM is $-0.126; its P/E ratio is -47.35; ADMA Biologics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 73.90M$ 67.27M$ 60.12M$ 56.91M$ 49.98M
Gross Profit$ 31.09M$ 24.65M$ 16.69M$ 16.51M$ 14.18M
EBIT$ -24.75M$ 8.94M$ -92.76K$ -5.33M$ -6.50M
EBITDA$ -21.98M$ 11.72M$ 2.66M$ -2.85M$ -6.32M
Net Income Common Stockholders$ -17.58M$ 2.54M$ -6.37M$ -6.81M$ -12.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.35M$ 74.16M$ 62.51M$ 69.20M$ 86.52M
Total Assets$ 329.18M$ 349.00M$ 343.00M$ 340.79M$ 348.46M
Total Debt$ 141.42M$ 152.97M$ 151.51M$ 155.73M$ 154.44M
Net Debt$ 90.07M$ 78.82M$ 89.00M$ 86.52M$ 67.92M
Total Liabilities$ 193.98M$ 197.56M$ 196.26M$ 195.13M$ 196.49M
Stockholders Equity$ 135.21M$ 151.44M$ 146.76M$ 145.65M$ 151.97M
Cash Flow-
Free Cash Flow$ 16.19M$ 11.23M$ -6.93M$ -16.67M$ -11.13M
Operating Cash Flow$ 17.60M$ 11.99M$ -6.06M$ -14.72M$ -7.38M
Investing Cash Flow$ -1.41M$ -756.56K$ -872.63K$ -1.94M$ -3.75M
Financing Cash Flow$ -38.99M$ 415.36K$ 240.12K$ -650.51K$ 62.74M
Currency in USD

ADMA Biologics Earnings and Revenue History

ADMA Biologics Debt to Assets

ADMA Biologics Cash Flow

ADMA Biologics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis